Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of
amoxicillin-clavulanic acid 400 mg-57 mg chewable tablets (test) versus Augmentin®
(reference) administered as 1 x 400 mg-57 mg chewable tablet under fasting conditions.